Constellium SE (NYSE:CSTM) Shares Sold by Kailix Advisors LLC

Kailix Advisors LLC lessened its stake in Constellium SE (NYSE:CSTM - Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,733,319 shares of the industrial products company's stock after selling 351,868 shares during the quarter. Constellium accounts for about 19.6% of Kailix Advisors LLC's portfolio, making the stock its largest holding. Kailix Advisors LLC owned about 1.21% of Constellium worth $17,489,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Allspring Global Investments Holdings LLC lifted its stake in Constellium by 51.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 51,966 shares of the industrial products company's stock worth $526,000 after purchasing an additional 17,655 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Constellium by 2,485.6% in the first quarter. GAMMA Investing LLC now owns 2,689 shares of the industrial products company's stock valued at $27,000 after acquiring an additional 2,585 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Constellium by 40.0% in the fourth quarter. Ameriprise Financial Inc. now owns 122,672 shares of the industrial products company's stock valued at $1,260,000 after buying an additional 35,080 shares in the last quarter. Deutsche Bank AG raised its stake in Constellium by 33.9% in the fourth quarter. Deutsche Bank AG now owns 125,389 shares of the industrial products company's stock valued at $1,288,000 after buying an additional 31,713 shares in the last quarter. Finally, Parallel Advisors LLC grew its holdings in shares of Constellium by 519.2% during the first quarter. Parallel Advisors LLC now owns 4,941 shares of the industrial products company's stock worth $50,000 after purchasing an additional 4,143 shares during the last quarter. Hedge funds and other institutional investors own 92.59% of the company's stock.

Constellium Price Performance

Shares of CSTM opened at $13.57 on Friday. Constellium SE has a twelve month low of $7.33 and a twelve month high of $18.98. The stock's 50 day moving average is $13.11 and its two-hundred day moving average is $11.19. The firm has a market capitalization of $1.94 billion, a PE ratio of 29.50 and a beta of 1.69. The company has a current ratio of 1.24, a quick ratio of 0.53 and a debt-to-equity ratio of 2.49.

Constellium (NYSE:CSTM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.19. Constellium had a return on equity of 7.74% and a net margin of 0.92%. The firm had revenue of $1.98 billion during the quarter, compared to the consensus estimate of $1.88 billion. During the same period in the previous year, the firm posted $0.11 EPS. The company's quarterly revenue was up 5.3% compared to the same quarter last year. Research analysts anticipate that Constellium SE will post 1.1 earnings per share for the current year.

Constellium Company Profile

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.

Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium SE (NYSE:CSTM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.